The results demonstrated decreased SLC20A1 expression levels after TLF-II intervention compared with that in the UTI and LVFX groups (Figures 7A–D), whereas Rab27b expression was elevated (Figures 7B, F). The gene discussed is RAB27B; the disease is bacterial urinary tract infection.